<DOC>
	<DOC>NCT00668616</DOC>
	<brief_summary>The purpose of this study is to determine whether a treatment with 4 cycles anthracycline + cyclophoshamide followed by administration of 4 cycles paclitaxel is more effective than therapy with 4 cy&lt;cles of anthracycline adminbistration followed by 4 cycles of paclitaxel</brief_summary>
	<brief_title>Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>women with histologically proven breast cancer (pT1/pT2/pT3, pN1, N0) ECOG performance status 01 start of adjuvant therapy not later than 4 weeks after surgery hematology: platelets at least 100xGpt/l, neutrophiles at least 2xGpt/l normal liver function as defined by: bilirubine till 1.5 x normal value, SGOT/SGPT till 1.25 x normal value normal kidney function as defined by: creatine till 1.5 x normal value negative pregnancy test for patients before menopause and effective contraception written informed consent prior radiation, chemotherapy, hormontherapy and immunotherapy patients with more than 3 afflicted lymph nodes afflicted lymph nodes on the cantralateal side and/or afflicted supraclavicular or intraclavicular lymph nodes bilateral breast cancer or second carcinoma of the breast inflammatory breast cancer and/or distant metastases existing clinically relevant peripheral neuropathie heart infection during the last 6 months or therapeutically not compensated heart failure or cardiac arrhythmias of at least LOWN II patients with active infections and/or not controlled hypercalcemia pregnant or breastfeeding women or women of childbearing age who do not use effictive contrazeptiva</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>breast cancer with 1-3 afflicted axillary lymph nodes</keyword>
</DOC>